CEACAM5 and silicosis: Tumour markers CEA, NSE, and CYFRA 21-1 are widely used for lung cancer screening and diagnosis [9-11,15]. This case demonstrated the combination of three clinical conditions diagnosed in one patient, including complicated silicosis associated with sarcoidosis and an elevated blood concentration of the NSE biomarker.